Toxicities of hyper-CVAD and imatinib mesylate in 91 postinduction courses
. | No. (%)* . | . | |
---|---|---|---|
Parameter . | Grades 1-2 . | Grades 3-4 . | |
Infections (overall)† | — | 23 (25) | |
FUO | — | 7 (8) | |
Pneumonia | — | 6 (7) | |
Bacterial | — | 3 (3) | |
Atypical | — | 2 (2) | |
Fungal/presumed fungal | — | 1 (1) | |
Sepsis | — | 9 (10) | |
GNR bacteremia | — | 5 (5) | |
Catheter-related bacteremia | — | 4 (4) | |
Other | — | 8 (9) | |
Sinusitis | — | 3 (3) | |
Osteomyelitis | — | 2 (2) | |
Herpes zoster | — | 2 (2) | |
Upper respiratory infections (RSV) | — | 1 (1) | |
Cardiovascular | |||
Fluid retention | 5 (25) | 1 (5) | |
Arrythmia (supraventricular) | 2 (10) | 2 (10) | |
Deep venous thrombosis | — | 2 (10) | |
Syncope | — | 2 (10) | |
Reduction in ejection fraction | 2 (10) | — | |
Hepatic | |||
Increase in bilirubin | 5 (25) | — | |
Increase in transaminases | 5 (25) | — | |
Neuromuscular | |||
Fatigue | 6 (30) | 2 (10) | |
Peripheral neuropathy | 6 (30) | 1 (5) | |
Headaches (postlumbar puncture) | 2 (10) | 2 (10) | |
Bone pain | 3 (15) | — | |
Myalgias | 2 (10) | — | |
Fracture (femur/vertebral) | — | 2 (10) | |
Gastrointestinal | |||
Stomatitis | 5 (25) | — | |
Constipation | 4 (20) | 1 (5) | |
Diarrhea | 2 (10) | 2 (10) | |
Nausea | 2 (10) | 1 (5) | |
Reflux | 1 (5) | 2 (10) | |
Ileus | — | 1 (5) | |
Coagulopathy | |||
Hypofibrinogenemia | 2 (10) | 1 (5) | |
Hemorrhage | |||
Gastrointestinal | — | 1 (5) | |
Skin | |||
Rash | 2 (10) | — | |
Renal | |||
Increase in creatinine | 5 (25) | — | |
Hyponatremia | — | 1 (5) |
. | No. (%)* . | . | |
---|---|---|---|
Parameter . | Grades 1-2 . | Grades 3-4 . | |
Infections (overall)† | — | 23 (25) | |
FUO | — | 7 (8) | |
Pneumonia | — | 6 (7) | |
Bacterial | — | 3 (3) | |
Atypical | — | 2 (2) | |
Fungal/presumed fungal | — | 1 (1) | |
Sepsis | — | 9 (10) | |
GNR bacteremia | — | 5 (5) | |
Catheter-related bacteremia | — | 4 (4) | |
Other | — | 8 (9) | |
Sinusitis | — | 3 (3) | |
Osteomyelitis | — | 2 (2) | |
Herpes zoster | — | 2 (2) | |
Upper respiratory infections (RSV) | — | 1 (1) | |
Cardiovascular | |||
Fluid retention | 5 (25) | 1 (5) | |
Arrythmia (supraventricular) | 2 (10) | 2 (10) | |
Deep venous thrombosis | — | 2 (10) | |
Syncope | — | 2 (10) | |
Reduction in ejection fraction | 2 (10) | — | |
Hepatic | |||
Increase in bilirubin | 5 (25) | — | |
Increase in transaminases | 5 (25) | — | |
Neuromuscular | |||
Fatigue | 6 (30) | 2 (10) | |
Peripheral neuropathy | 6 (30) | 1 (5) | |
Headaches (postlumbar puncture) | 2 (10) | 2 (10) | |
Bone pain | 3 (15) | — | |
Myalgias | 2 (10) | — | |
Fracture (femur/vertebral) | — | 2 (10) | |
Gastrointestinal | |||
Stomatitis | 5 (25) | — | |
Constipation | 4 (20) | 1 (5) | |
Diarrhea | 2 (10) | 2 (10) | |
Nausea | 2 (10) | 1 (5) | |
Reflux | 1 (5) | 2 (10) | |
Ileus | — | 1 (5) | |
Coagulopathy | |||
Hypofibrinogenemia | 2 (10) | 1 (5) | |
Hemorrhage | |||
Gastrointestinal | — | 1 (5) | |
Skin | |||
Rash | 2 (10) | — | |
Renal | |||
Increase in creatinine | 5 (25) | — | |
Hyponatremia | — | 1 (5) |